Yesterday (2 October), Ferronordic hosted its 2024 CMD.
Redeye takes a positive stance towards the acquisition of Visual Art.
Analyst Group har med Umida Group ingått avtal om kontinuerlig analysbevakning, innefattande bl.
Endomines’ Q3 production was fairly well in line with our estimates at 4,191 ounces (Evli est.
Cereno Scientific has reported positive top-line results for the Phase IIa CS1-003 trial, which eval...
AcuCort (”AcuCort” eller ”Bolaget”) meddelade den 2 oktober år 2024 att Bolaget har beviljats förlän...
TCECUR Sweden AB (”TCECUR” eller ”Koncernen”) meddelade den 1 oktober 2024 att Sectragon Internation...
Redsense presenterar ett starkt andra kvartal med en rekordomsättning.
Redeye comments on the two announcements about receiving USD6.
Refine Group AB (”Refine”, ”Koncernen” eller ”Bolaget”) meddelade den 30 september år 2024 att dotte...
IRLAB Therapeutics has announced the completion of patient enrolment for the Phase IIb trial (React ...
Redeye has updated its fair value range for Lifecare following the company's reverse share split, a ...
Redeye comments briefly on the appointment of Philippe Cohen as new CEO while we leave our estimates...
Redeye comments on the news that the CEO is departing the company.
Redeye expects Smart Eye's Q3, due 14 November, to show a 21% y/y sales growth, EBITDA of SEK -19m, ...
Redeye initiates coverage of Fable Media Group, an affiliate company with stellar financial performa...
Redeye gives a short comment on today’s news that IRLAB has enrolledthe last patient in the ongoing ...
Redeye leaves a short comment following Cinclus’ recent announcement that the manufacturing of the I...
Redeye initiates coverage of MindArk, a Swedish gaming company with a long-standing presence in the ...
Ramlösa Shipping (”Ramlösa” eller ”bolaget”) meddelade den 27 september år 2024 att bolagets fartygs...
